Mechanism of selective motor neuronal death after exposure of spinal cord to glutamate: Involvement of glutamate-induced nitric oxide in motor neuron toxicity and nonmotor neuron protection

Annals of Neurology

Volumn 44, Issue 5, 1998, Pages 796-807

  Urushitani, Makoto ^a   Shimohama, Shun ^a   Kihara, Takeshi ^a   Sawada, Hideyuki ^a   Akaike, Akinori ^a   Ibi, Masakazu ^a   Inoue, Ryotaku ^a   Kitamura, Yoshihisa ^b   Taniguchi, Takashi ^b   Kimura, Jun ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

8 BROMO CYCLIC AMP; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; GLUTAMIC ACID; GUANYLATE CYCLASE INHIBITOR; KAINIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; NITRIC OXIDE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL TISSUE; ARTICLE; DRUG INDUCED DISEASE; ENZYME INHIBITION; EXPOSURE; EXTRACELLULAR SPACE; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MOTOR NEURON DISEASE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD;

EID: 0031795392     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410440514     Document Type: Article

References (61)

1. Perry TL, Hansen S, Jones K. Brain glutamate deficiency in amyotrophic lateral sclerosis. Neurology 1987;37:1845-1848
2. Plaitakis A, Constantakakis E, Smith J. The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis. Ann Neurol 1988;24:446-449
3. Couratier P, Hugon J, Sindou P, et al. Cell culture evidence for neuronal degeneration in amyotrophic lateral sclerosis being linked to glutamate AMPA/kainate receptors. Lancet 1993;341: 265-268
4. Rothstein JD, Van Kammen M, Levey AI, et al. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 1995;38:73-84
5. Shaw PJ, Forrest V, Ince PG, et al. CSF and plasma amino acid levels in motor neuron disease: elevation of CSF glutamate in a subset of patients. Neurodegeneration 1995;4:209-216
6. Lin C-LG, Bristol LA, Jin L, et al. Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 1998;20:589-602
7. Morselli PL, Garattini S. Monosodium glutamate and the Chinese restaurant syndrome. Nature 1970;227:611-612
8. Olney JW, Ho OL, Rhee V, DeGubareff T. Neurotoxic effects of glutamate. N Engl J Med 1973;289:1374-1375 (Letter)
9. Choi DW. Excitotoxic cell death. J Neurobiol 1992;23:1261-1276
10. Rothstein JD, Jin L, Dykes-Hoberg M, Kuncl RW. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc Natl Acad Sci USA 1993;90:6591-6595
11. Carriedo SG, Yin HZ, Weiss JH. Motor neurons are selectively vulnerable to AMPA/kainate receptor-mediated injury in vitro. J Neurosci 1996;16:4069-4079
12. Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988;1:623-634
13. Pellegrini-Giampietro DE, Cherici G, Alesiani M, et al. Excitatory amino acid release and free radical formation may cooperate in the genesis of ischemia-induced neuronal damage. J Neurosci 1990;10:1035-1041
14. Lafon-Cazal M, Pietri S, Culcasi M, Bockaert J. NMDA-dependent superoxide production and neurotoxicity. Nature 1993;364:535-537
15. Cheng Y, Sun AY. Oxidative mechanisms involved in kainate-induced cytotoxicity in cortical neurons. Neurochem Res 1994; 19:1557-1564
16. Duan LL, Sensi SL, Canzonicro LM, et al. Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-D-aspartate. J Neurosci 1995;15:6377-6388
17. Dawson VL, Dawson TM. Physiological and toxicological actions of nitric oxide in the central nervous system. Adv Pharmacol 1995;34:323-342
18. Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;362:59-62
19. Beckman JS, Carson M, Smith CD, Koppenol WH. ALS, SOD and petoxynitrite. Nature 1993;364:584 (Letter)
20. Rothstein JD, Kuncl RW. Neuroprotective strategies in a model of chronic glutamate-mediated motor neuron toxicity. J Neurochem 1995;65:643-651
21. Chou SM, Wang HS, Taniguchi A. Role of SOD-1 and nitric oxide/cyclic GMP cascade on neurofilament aggregation in ALS/MND. J Neurol Sci 1996;139:16-26
22. Bruning G. Localization of NADPH diaphorase, a histochemical marker for nitric oxide synthase, in the mouse spinal cord. Acta Histochem 1992;93:397-401
23. Saito S, Kidd GJ, Trapp BD, et al. Rat spinal cord neurons contain nitric oxide synthase. Neuroscience 1994;59:447-456
24. Dwyer BE, Nishimura RN, Lu SY. Differential localization of heme oxygenase and NADPH-diaphorase in spinal cord neurons. Neuroreport 1995;6:973-976
25. Wu Y, Li Y, Liu H, Wu W. Induction of nitric oxide synthase and motoneuron death in newborn and early postnatal rats following spinal root avulsion. Neurosci Lett 1995;194:109-112
26. Clowry GJ, McHanwell S. Expression of nitric oxide synthase by motor neurones in the spinal cord of the mutant mouse wobbler. Neurosci Lett 1996;215:177-180
27. Samdani AF, Newcamp C, Resink A, et al. Differential susceptibility to neurotoxicity mediated by neurotrophins and neuronal nitric oxide synthase. J Neurosci 1997;17:4633-4641
28. Lee MA, Cai L, Hubner N, et al. Tissue- and development-specific expression of multiple alternatively spliced transcripts of rat neuronal nitric oxide synthase. J Clin Invest 1997;100: 1507-1512
29. Lipton SA, Singel DJ, Stamler JS. Neuroprotective and neurodestructive effects of nitric oxide and redox congeners. Ann NY Acad Sci 1994;738:382-387
30. Wink DA, Cook JA, Pacelli R, et al. Nitric oxide (NO) protects against cellular damage by reactive oxygen species. Toxicol Lett 1995;82-83:221-226
31. Kashii S, Mandai M, Kikuchi M, et al. Dual actions of nitric oxide in N-methyl-D-aspartate receptor-mediated neurotoxicity in cultured retinal neurons. Brain Res 1996;711:93-101
32. Tenneti L, D'Emilia DM, Lipton SA. Suppression of neuronal apoptosis by S-nitrosylation of caspases. Neurosci Lett 1997; 236:139-142
33. Melino G, Bernassola F, Knight RA, et al. S-Nitrosylation regulates apoptosis. Nature 1997;388:432-433
34. Spike RC, Todd AJ, Johnston HM. Coexistence of NADPH diaphorase with GABA, glycine, and acetylcholine in rat spinal cord. J Comp Neurol 1993;335:320-333
35. Pullen AH, Humphreys P. Diversity in localisation of nitric oxide synthase antigen and NADPH-diaphorase histochemical staining in sacral somatic motor neurones of the cat. Neurosci Lett 1995;196:33-36
36. Michikawa M, Lim KT, McLarnon JG, Kim SU. Oxygen radical-induced neurotoxicity in spinal cord neuron cultures. J Neurosci Res 1994;37:62-70
37. Kitamura Y, Arima T, Imaizumi R, et al. Inhibition of constitutive nitric oxide synthase in the brain by pentamidine, a calmodulin antagonist. Eur J Pharmacol 1995;289:299-304
38. Sawada H, Shimohama S, Kawamura T, et al. Mechanism of resistance to NO-induced neurotoxicity in cultured rat dopaminergic neurons. J Neurosci Res 1996;46:509-518
39. Sawada H, Kawamura T, Shimohama S, et al. Different mechanisms of glutamate-induced neuronal death between dopaminergic and non-dopaminergic neurons in rat mesencephalic culture. J Neurosci Res 1996;43:503-510
40. Gotow T, Tanaka J. Phosphorylation of neurofilament H subunit as related to arrangement of neurofilaments. J Neurosci Res 1994;37:691-713
41. Dun NJ, Dun SL, Wu SY, et al. Nitric oxide synthase immunoreactivity in the rat, mouse, cat and squirrel monkey spinal cord. Neuroscience 1993;54:845-857
42. Hugon J, Vallat JM, Spencer PS, et al. Kainic acid induces early and delayed degenerative neuronal changes in rat spinal cord. Neurosci Lett 1989;104:258-262
43. Williams TL, Day NC, Ince PG, et al. Calcium-permeable α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors: a molecular determinant of selective vulnerability in amyotrophic lateral sclerosis. Ann Neurol 1997;42:200-207
44. Gredal O, Pakkenberg B, Nielsen M. Muscarinic, N-methyl-D-aspartate (NMDA) and benzodiazepine receptor binding sites in cortical membranes from amyotrophic lateral sclerosis patients. J Neurol Sci 1996;143:121-125
45. Virgo L, de Belleroche J. Induction of the immediate early gene c-jun in human spinal cord in amyotrophic lateral sclerosis with concomitant loss of NMDA receptor NR-1 and glycine transporter mRNA. Brain Res 1995;676:196-204
46. Samarasinghe S, Virgo L, de Belleroche J. Distribution of the N-methyl-D-aspartate glutamate receptor subunit NR2A in control and amyotrophic lateral sclerosis spinal cord. Brain Res 1996;727:233-237
47. Przedborski S, Donaldson D, Jakowec M, et al. Brain superoxide dismutase, catalase, and glutathione peroxidase activities in amyotrophic lateral sclerosis. Ann Neurol 1996;39:158-165
48. Pardo CA, Xu Z, Borchelt DR, et al. Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons. Proc Natl Acad Sci USA 1995;92:954-958
49. Wiedau-Pazos M, Goto JJ, Rabizadeh S, et al. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 1996;271:515-518
50. Chou SM, Wang HS, Komai K. Colocalization of NOS and SOD1 in neurofilament accumulation within motor neurons of amyotrophic lateral sclerosis: an immunohistochemical study. J Chem Neuroanat 1996;10:249-258
51. Hrabie JA, Klose JR, Wink DA, Keefer LK. New nitirc oxide-releasing Zwitterions derived from polyamines. J Org Chem 1993;58:1472-1476
52. Satake N, Zhou Q, Sato N, et al. Characteristics of vasoinhibitory action of FK 453 (a pyrazolo-pyridine derivative), a new antihypertensive agent with diuretic action in isolated rabbit aorta. Pharmacology 1992;44:206-214
53. Forloni G, Lucca E, Angeretti N, et al. Neuroprotective effect of somatostatin on nonapoptotic NMDA-induced neuronal death: role of cyclic GMP. J Neurochem 1997;68:319-327
54. Barger SW, Fiscus RR, Ruth P, et al. Role of cyclic GMP in the regulation of neuronal calcium and survival by secreted forms of β-amyloid precursor. J Neurochem 1995;64:2087-2096
55. Brenneman DE, Fitzgerald S, Litzinger MJ. Neuronal survival during electrical blockade is increased by 8-bromo cyclic adenosine 3′,5′ monophosphate. J Pharmacol Exp Ther 1985;233: 402-408
56. Dinerman JL, Steiner JP, Dawson TM, et al. Cyclic nucleotide dependent phosphorylation of neuronal nitric oxide synthase inhibits catalytic activity. Neuropharmacology 1994;33:1245-1251
57. Ozaki S, Snider WD. Initial trajectories of sensory axons toward laminar targets in the developing mouse spinal cord. J Comp Neurol 1997;380:215-229
58. Phelps PE, Barber RP, Vaughn JE. Embryonic development ofrat sympathetic preganglionic neurons: possible migratory substrates. J Comp Neurol 1993;330:1-14
59. Shaw PJ, Chinnery RM, Ince PG. [3H]D-aspartate binding sites in the normal human spinal cord and changes in motor neuron disease: a quantitative autoradiographic study. Brain Res 1994;655:195-201
60. Trotti D, Rossi D, Gjesdal O, et al. Peroxynitrite inhibits glutamate transporter subtypes. J Biol Chem 1996;271:5976-5979
61. Volterra A, Trotti D, Tromba C, et al. Glutamate uptake inhibition by oxygen free radicals in rat cortical asrrocytes. J Neurosci 1994;14:2924-2932